KemPharm to Present Data at PAINWeek 2016
Sep 08, 2016 11:30 am UTC| Business
CORALVILLE, Iowa, Sept. 08, 2016 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, today announced it will present data...
Sep 08, 2016 11:30 am UTC| Business
BERKELEY HEIGHTS, N.J., Sept. 08, 2016 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life-threatening conditions,...
WestRock Announces Consumer and Corrugated Leadership
Sep 08, 2016 11:30 am UTC| Business
NORCROSS, Ga., Sept. 08, 2016 -- WestRock Company(NYSE:WRK), a leading provider of differentiated paper and packaging solutions, today announced that Bob Feeser has been named president of Consumer Packaging and Jeff...
Cytokinetics Announces Next-Generation Fast Skeletal Muscle Activator Entering IND-Enabling Studies
Sep 08, 2016 11:30 am UTC| Business
Triggers Milestone Payment from Astellas;Expands Portfolio of Skeletal Muscle Activators SOUTH SAN FRANCISCO, Calif., Sept. 08, 2016 -- Cytokinetics, Inc. (Nasdaq:CYTK) today announced the initiation of IND-enabling...
Caladrius Biosciences to Present at Upcoming September Conferences
Sep 08, 2016 11:30 am UTC| Business
BASKING RIDGE, N.J., Sept. 08, 2016 -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a cell therapy company combining an industry-leading development and manufacturing services provider (PCT)...
Provision Hires Experienced Media Exec to Boost Ad Revenues
Sep 08, 2016 11:30 am UTC| Business
CHATSWORTH, Calif., Sept. 08, 2016 -- Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO), today announced it has hired advertising executive Joseph (“Joe”)...
AveXis Announces Pricing of Public Offering of Common Stock
Sep 08, 2016 11:25 am UTC| Business
CHICAGO, Sept. 08, 2016 -- AveXis, Inc. (NASDAQ:AVXS) today announced the pricing of an underwritten public offering of 4,250,000 shares of its common stock, 3,960,145 shares of which are being offered by AveXis and...